Biochemical and Molecular Actions of Interleukin-1 on Pancreatic β-Cells

References

• Eisenbarth O S. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Foulis A K. The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J Pathol 1987; 152: 141–148
   PubMed Web of Science ®Google Scholar
• Schwizer R W, Leiter E H, Evans R. Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. Transplantation 1984; 37: 539–544
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Høiris Nielsen J, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 1985; 40: 424–429
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg Nielsen J. JH. Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 1986; 41: 250–259
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C A, Svenson M, Nielsen J H. Affinity-purified human interleukin 1 is cytotoxic to islet cells of Langerhans. Diahetologia 1986; 29: 63–67
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen J H., Dinarello C A, Svenson M. Cytotoxicity of human p17 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J. The HLA-IDDM association; implications for etiology and pathogenesis of 1DDM. Diab/Metab Rev 1987; 3: 779–802
   PubMed Web of Science ®Google Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L, Egeberg J. Mechanism of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care, 11: 16–23, (Suppl. 1)
   PubMed Web of Science ®Google Scholar
• Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989; 2: 177–189
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Helqvist S, Mølvig J, Wogensen L D, Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin dependent diabetes mellitus. Autoimmunity 1989; 4: 191–218
   PubMedGoogle Scholar
• Sims J E, March C J, Cosman D, Widmer M B, MacDonald H, Mc R., Mahan C J, Grubin C E, Wignall J M, Jackson J L, Call S M, Friend D, Alpert A R, Gillis S, Urdal D L, Dower S K. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988; 241: 585–589
   PubMed Web of Science ®Google Scholar
• Sims J E, Acres R B, Grubin C E, Mc Mahan C J, Wignall J M, March C J, Dower S K. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci USA 1989; 86: 8946–8950
   PubMed Web of Science ®Google Scholar
• Bomsztyk K, Sims J E, Stanton T H, Slack J, Mc Mahan C J, Valentine M A, Dower S K. Evidence for different interleukin 1 receptors in murine B-and T-cell lines. Proc Natl Acad Sci USA 1989; 86: 8034–8038
   PubMed Web of Science ®Google Scholar
• Chizzonite R, Truitt T, Kilian P L, Stern A S, Nunes P, Parker K P, Kaffka K L, Chua A O, Lugg D K, Gubler U. Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci USA 1989; 86: 8029–8033
   PubMed Web of Science ®Google Scholar
• Matsushima K, Akahoshi T, Yamada M, Furutani Y, Oppenheim J J. Properties of a specific interleukin 1 (IL I) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-α and IL 1-β. J Immunol 1986; 136: 4496–4502
   PubMed Web of Science ®Google Scholar
• Munoz E, Beutner U, Zubiaga A, Huber B T. IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 1990; 144: 964–969
   PubMed Web of Science ®Google Scholar
• Munoz E, Zubiaga A M, Sims J E, Huber B T. IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T-cells. J Immunol 1991; 146: 136–143
   PubMed Web of Science ®Google Scholar
• Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz R J. Insulin-secreting β-cells possess specific receptors for interleukin-1β. FEBS Lett 1990; 261: 97–100
   PubMed Web of Science ®Google Scholar
• Eizirik D L, Tracey D E, Bendtzen K, Sandier S. An interleukin-1 receptor antagonist protein (IRAP) protects insulin-producing Beta cells against suppressive effects of interleukin-1 β. Diabetologia 1991; 34: 445–448
   PubMed Web of Science ®Google Scholar
• Carter D B, Deibel M R, Dunn C J, Tomic C-SC, Laborde A L, Slightom J, Berger A E, Bienkowski M J, Sun F F, Mc Ewan R N, Harris P KW, Yem A W, Waszak G A, Chosay J G, Sieu L C, Hardee M M, Zurcher-Neely H A, Reardon I M, Heinrikson R L, Truesdell S E., Shelly J A, Eessalu T E, Taylor B M, Tracey D E. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344: 633–638
   PubMed Web of Science ®Google Scholar
• Dayer-Metroz M-D, Wollheim C B, Seckinger P, Dayer J-M. A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmunity 1989; 2: 163–171
   PubMed Web of Science ®Google Scholar
• Qvarnstrom E E, Page R C, Gillis S, Dower S K. Binding, internalization, and intracellular localization of interleukin-1β in human diploid fibroblasts. J Biol Chem 1988; 263: 8261–8269
   PubMed Web of Science ®Google Scholar
• Curtis B M, Widmer M B, de Roos P, Qvarnstrom E E. IL-1 and its receptor are translocated to the nucleus. J Immunol 1990; 144: 1295–1303
   PubMed Web of Science ®Google Scholar
• McDanlel M L, Hughes J H., Wolf B A, Easom R A, Turk J. Descriptive and mechanistic considerations of interleukin 1 and insulin secretion. Diabetes 1988; 37: 1311–1315
   PubMed Web of Science ®Google Scholar
• Chedid M, Shirakawa F, Naylor P, Mizel S B. Signal transduction for IL-1. Involvement of a pertussis toxin-sensitive GTP-binding protein in the activation of adenylate cyclase. J Immunol 1989; 142: 4301–4306
   PubMed Web of Science ®Google Scholar
• O'Neill L AJ, Bird T A, Saklatvala J. Interleukin I signal transduction. Immunol Today 1990; 11: 392–394
   PubMedGoogle Scholar
• Dobson P RM, Plested C P, Jones D, Barks R. T, Brown B L. Interleukin-1 induces a pertussis toxin-sensitive increase in diaceylglycerol accumulation in mouse thymoma cells. J Mol Endocr 1989; 2: R5–R8
   Web of Science ®Google Scholar
• Mizel S B. Cyclic AMP and interleukin 1 signal transduction. Immunol Today 1990; 11: 390–391
   PubMedGoogle Scholar
• Sandier S, Bendtzen K, Eizirik D L, Strandell E, Welsh M, Welsh N. Metabolism and β-cell function of rat pancreatic islets exposed to human interleukin-1β in the presence of a high glucose concentration. Immunol Lett 1990; 26: 245–252
   PubMed Web of Science ®Google Scholar
• Eizirik D, Welsh L. M, Strandell E, Welsh N, Sandier S. Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 1990; 127: 2290–2297
   PubMed Web of Science ®Google Scholar
• Wijelath E S, Kardasz A M, Drummond Watson R. J. Interleukin-1 induced inositol phospholipid breakdown in murine macrophages: possible mechanism of receptor activation. Biochem Biophys Res Commun 1988; 152: 392–397
   PubMed Web of Science ®Google Scholar
• Rosoff P M, Savage N, Dinarello C A. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 1988; 54: 73–81
   PubMed Web of Science ®Google Scholar
• Kester M, Simonson M S, Mené P, Sedor J R. [nterleukin-1 generates transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells. J Clin Invest 1989; 83: 718–723
   PubMed Web of Science ®Google Scholar
• Welsh N, Nilsson T, Hallberg A, Arkhammar P, Berggren P-O, Sandier S. Human interleukin 1β stimulates islet insulin release by a mechanism not dependent on changes in phospho-lipase C and protein kinase C activities or Ca2+ handling. Acta Endocrinol (Copenh) 1989; 121: 698–704
   PubMedGoogle Scholar
• Zawalich W S, Dierdolf B, Zawalich K C. Interleukin-1 induces time-dependent potentiation in isolated rat islets: possible involvement of phosphoinositide hydrolysis. Endocrinology 1989; 124: 720–726
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Zawalich K C, Rasmussen H. Interleukin-1α exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion. Endocrinology 1989; 124: 2350–2357
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Zawalich K C. Interleukin-1 is a potent stimulator of islet insulin secretion and phosphoinositide hydrolysis. Am J Physiol 1989; 256: E19–E24
   Google Scholar
• Hughes J H, Easom R A, Wolf B A, Turk J, McDaniel M L. Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Diabetes 1989; 38: 1251–1257
   PubMed Web of Science ®Google Scholar
• Sandier S, Bendtzen K, Borg L AH, Eizirik D L, Strandell E, Welsh N. Studies on the mechanism causing inhibition of insulin secretion in rat pancreatic islets exposed to interleukin-1/3 indicate a perturbation in the mitochondrial function. Endocrinology 1989; 124: 1492–1501
   PubMed Web of Science ®Google Scholar
• Wogensen L D, Kolb-Bachofen V, Christensen P, Dinarello C A, Mandrup-Poulsen T, Martin S, Nerup J. Functional and morphological effects of interleukin-1β on the perfused rat pancreas. Diabetologia 1990; 33: 15–23
   PubMed Web of Science ®Google Scholar
• Kaur P, Welch W J, Saklatvala J. Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells. FEES Lett 1989; 258: 269–273
   PubMed Web of Science ®Google Scholar
• Bird T A, Saklatvala J. Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654. J Biol Chem 1990; 265: 235–240
   PubMed Web of Science ®Google Scholar
• Matushima K, Masahiro S, Kung H, Copeland T D. Purification and characterization of a phosphoprotein in human leukocytes whose phosphorylation is augmented by stimulation with interleukin-1. Biochemistry 1988; 27: 3765–3770
   PubMed Web of Science ®Google Scholar
• Gallis B, Prickett K S, Jackson J, Slack J, Schooley K, Sims J E, Dower S K. IL-1 induces rapid phosphorylation of the IL-1 receptor. J Immunol 1989; 141: 3235–3240
   Google Scholar
• Fagarasan M O, Bishop J F, Rinaudo M S, Axelrod J. Interleukin 1 induces early protein phosphorylation and requires only a short exposure for late induced secretion of β-endorphin in a mouse pituitary cell line. Proc Natl Acad Sci USA 1990; 87: 2555–2559
   PubMed Web of Science ®Google Scholar
• Martin M, Lovett D H, Szamel M, Resch K. Characterization of the interleukin-1-induced tyrosine phosphorylation of a 41-kDa plasma membrane protein of the human tumor cell line K 562. Eur J Biochem 1989; 180: 343–350
   PubMedGoogle Scholar
• Helqvist S, Bouchelouche P, Andersen H U, Nerup J. Modulation of calciumflux influences interleukin 1β effects on insulin release from isolated islets of Langerhans. Acta Endocrinol (Copenh) 1989; 121: 447–455
   PubMedGoogle Scholar
• Borg L AH, Eizirik D L. Short-term exposure of rat pancreatic islets to human interleukin-1β increases cellular uptake of calcium. Immunol Lett 1990; 26: 253–258
   PubMed Web of Science ®Google Scholar
• Helqvist S, Bouchelouche P N, Johannesen, Nerup J. Interleukin 1β increases the cytosolic free sodium concentration in isolated rat islets of Langerhans. Scand J Immunol 1990; 32: 53–58
   PubMed Web of Science ®Google Scholar
• Eizirik D L, Bendtzen K, Sandier S. Short exposure of rat pancreatic islets to interleukin-1β induces a sustained but reversible impairment in β-cell function: influence of protease activation, gene transcription, and protein translation. Endocrinology 1991; 128: 1611–1616
   PubMed Web of Science ®Google Scholar
• Helqvist S, Polla B S, Johannesen J, Nerup J. Heat shock protein induction in rat pancreatic islets by human recombinant interleukin 1β. Diabetologia 1991; 34: 150–156
   PubMed Web of Science ®Google Scholar
• Endo Y, Matsushima K, Onozaki K, Oppenheim J J. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. J Immunol 1988; 141: 2342–2348
   PubMed Web of Science ®Google Scholar
• Welsh N, Sjöholm Å. Polyamines and insulin production in isolated mouse pancreatic islets. Biochem J 1988; 252: 701–707
   PubMed Web of Science ®Google Scholar
• Sandier S, Bendtzen K, Eizirik D L, Sjöholm A, Welsh N. Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1β. Immunol Lett 1989; 22: 267–272
   PubMed Web of Science ®Google Scholar
• Meikle M C, Atkinson S J, Ward R V, Murphy G, Reynolds J J. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin-1: evidence that breakdown is mediated by metalloproteinases. J Periodont Res 1989; 24: 207–213
   PubMed Web of Science ®Google Scholar
• Suffys P, Beyaert R, Van Rof F, Fiers W. Involvement of a serine protease in tumour-necrosis factor mediated cytotoxicity. Eur J Biochem 1988; 178: 257–265
   PubMedGoogle Scholar
• Welsh N, Bendtzen K, Sandier S. Influence of protease on inhibitory and stimulatory effects of interleukin 1β on β-cell function. Diabetes 1991; 40: 290–294
   PubMed Web of Science ®Google Scholar
• Southern C, Schulster D, Green I C. Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-or via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990; 276: 42–44
   PubMed Web of Science ®Google Scholar
• Spinas G A, Hansen B S, Linde S, Kastern W, Mølvig J, Mandrup-Poulsen T, Dinarello C A, Nielsen J H, Nerup J. Interleukin-1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 1987; 30: 474–480
   PubMed Web of Science ®Google Scholar
• Hansen B S, Nielsen J H, Linde S, Spinas G A, Welinder S, Mandrup-Poulsen T, Nerup J. Effect of interleukin-1 on the biosynthesis of proinsulin and insulin in isolated rat pancreatic islets. Biomed Biochim Acta 1988; 47: 305–309
   PubMedGoogle Scholar
• Sandier S, Andersson A, Hellerström C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Helqvist S, Hansen B S, Johannesen J, Andersen H U, Nielsen J H, Nerup J. Interleukin 1 induces new protein formation in isolated rat islets of Langerhans. Acta Endocrinol (Copenh) 1989; 121: 136–140
   PubMedGoogle Scholar
• Welsh N, Welsh M, Lindquist S, Eizirik D L, Bendtzen K, Sandier S. Interleukin-1β increases the biosynthesis of the heat shock protein hsp70 and selectively decreases the biosynthesis of five proteins in rat pancreatic islets. Autoimmunity 1991; 9: 33–40
   PubMed Web of Science ®Google Scholar
• Hughes J H, Colca J R, Easom R A, Turk J, McDaniel M L. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 1990; 86: 856–863
   PubMed Web of Science ®Google Scholar
• Lindquist S, Craig E A. The heat shock proteins. Ann Rev Genet 1988; 22: 631–677
   PubMed Web of Science ®Google Scholar
• Pelham H RB. Heat shock and the sorting of luminal ER proteins. EMBO J 1989; 8: 3171–3176
   PubMed Web of Science ®Google Scholar
• Marguiis B A, Welsh M. Analysis of protein-binding to heat shock protein 70 in pancreatic islet cells exposed to elevated temperatures or interleukin-1β. J Biol Chem 1991; 266: 9295–9298
   PubMed Web of Science ®Google Scholar
• Margulis B A, Sandier S, Eizirik D L, Welsh N, Welsh M. Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets protects against interleukin-1 β impaired β-cell function. Diabetes 1991, (In press)
   PubMed Web of Science ®Google Scholar
• Rasmussen B, Wohlrab B. Bovine cardiac mitochondria! ADP/ATP carrier: two distinct mRNAs and an unusually short 3'-noncoding sequence. Biochem Biophys Res Commun 1986; 138: 850–857
   PubMed Web of Science ®Google Scholar
• Welsh N, Svensson C, Welsh M. Content of adenine nucleotide translocator mRNA in insulin-producing cells of different functional states. Diabetes 1989; 38: 1377–1380
   PubMed Web of Science ®Google Scholar
• Svensson C, Welsh N, Krawetz S A, Welsh M. Exhibition of specific alterations in activities and mRNA levels of rat islet glycolytic and mitochondrial enzymes in three different in vitro model systems of attenuated insulin release. Diabetes 1991; 40: 771–776
   PubMed Web of Science ®Google Scholar
• Eizirik D L. Interleukin-1β induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 1991, (In press)
   Web of Science ®Google Scholar
• Hughes J H, Watson M A, Easom R A, Turk J, McDaniel M L. Interleukin-1 induces rapid and transient expression of the cfos proto-oncogene in isolated pancreatic islets and in purified β-cells. FEBS Lett 1990; 266: 33–36
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin J-X, Yip Y K, Vilcek J. Enhancement of cAMP levels and protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: Role in the induction of interleukin 6. Proc Natl Acad Sci USA 1988; 85: 6802–6805
   PubMed Web of Science ®Google Scholar
• Campbell I L, Cutri A, Wilson A, Harrison L C. Evidence for IL-6 production by and effects on the pancreatic β-cell. J Immunol 1989; 143: 1188–1191
   PubMed Web of Science ®Google Scholar
• Sandier S, Bendtzen K, Eizirik D L, Welsh M. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinology 1990; 126: 1288–1294
   PubMed Web of Science ®Google Scholar
• Southern C, Schulster D, Green I C. Inhibition of insulin secretion from rat islets of Langerhans by interleukein-6. An effect distinct from that of interleukin-1. Biochem J 1990; 272: 243–245
   PubMed Web of Science ®Google Scholar
• Buschard K, Aaen K, Horn T, Van Damme J, Bendtzen K. Interleukin 6: A functional and structural in vitro modulator of beta-cells from islets of Langerhans. Autoimmunity 1990; 5: 185–194
   PubMed Web of Science ®Google Scholar
• Comens P G, Wolf B A, Unanue E R, Lacy P E, McDaniel M L. Interleukin 1 is a potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 1987; 36: 963–970
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Diaz V A. Interleukin 1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 1986; 35: 1119–1123
   PubMed Web of Science ®Google Scholar
• Leiter E H. Murine macrophages and pancreatic β-cells. Chemotactic properties of insulin and β-cytostatic action of interleukin-1. J Exp Med 1987; 166: 1174–1179
   PubMed Web of Science ®Google Scholar
• Rabinovitch A, Sumoski W, Rajotte R V, Warnock G L. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer cultures. J Clin Endocrinol Metab 1990; 71: 152–156
   PubMed Web of Science ®Google Scholar
• Spinas G A, Mandrup-Poulsen T, Mølvig J, Baek L, Bendtzen K, Dinarello C A, Nerup J. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol (Copenh) 1986; 113: 551–558
   PubMedGoogle Scholar
• Spinas G A, Palmer J, Mandrup P., Poulsen T, Andersen H, Nielsen J H, Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta-cells—stimulation followed by inhibition—depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol (Copenh) 1988; 119: 307–311
   PubMedGoogle Scholar
• Eizirik D L, Sandier S. Human interleukin-1β induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events. Diabetologia 1989; 32: 769–773
   PubMed Web of Science ®Google Scholar
• Eizirik D L, Strandell E, Bendtzen K, Sandier S. Functional characteristics of rat pancreatic islets maintained in culture following exposure to human interleukin 1. Diabetes 1988; 37: 916–919
   PubMed Web of Science ®Google Scholar
• Rabinovitch A, Pukel C, Baquerizo H. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology 1988; 122: 2393–2398
   PubMed Web of Science ®Google Scholar
• Eizirik D L, Sandier S, Hallberg A, Bendtzen K, Sener A, Malaisse W J. Differential sensitivity to β-cell secretagogues in rat pancreatic islets exposed to human interleukin-1β. Endocrinology 1989; 125: 752–759
   PubMed Web of Science ®Google Scholar
• Ganda O P, Srikanta S, Brink S J, Morris M A, Gleasom R E, Soeldner J S, Eisenbarth G S. Differential sensitivity to β-cell secretagogues in “early” type I diabetes mellitus. Diabetes 1984; 33: 516–521
   PubMed Web of Science ®Google Scholar
• Malaisse W J. Insulin release: the fuel concept. Diabet Metab 1983; 9: 313–320
   Google Scholar
• Prentki M, Matschinsky F M. Ca2+, cAMP and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 1987; 67: 1185–1248
   PubMed Web of Science ®Google Scholar
• MacDonald M J. Elusive proximal signals of β-cells for insulin secretion. Diabetes 1990; 39: 1461–1466
   PubMed Web of Science ®Google Scholar
• Charles S, Tamagawa T, Henquin J C. A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochem J 1982; 208: 301–308
   PubMed Web of Science ®Google Scholar
• Malaisse W J, Pipeleers D O, Levy J. The stimulus-secretion coupling of glucose-induced insulin release. XVI. A glucose-like and Ca2+ independent effect of cAMP. Biochim Biophys Acta 1974; 362: 121–128
   PubMed Web of Science ®Google Scholar
• Eizirik D L. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol (Copenh) 1988; 119: 321–325
   PubMedGoogle Scholar
• Beggs M, Beresford G, Clarke J, Mertz R, Espinal J, Hammonds P. Interleukin-1β inhibits glucokinase activity in clonal HIT-T15 β-cells. FEBS Lett 1990; 267: 217–220
   PubMed Web of Science ®Google Scholar
• Wolf B A, Hughes J H, Florholmen J, Turk J, McDaniel M L. Interleukin 1 inhibits glucose-induced Ca2+ uptake by islets of Langerhans. FEBS Lett 1989; 248: 35–38
   PubMed Web of Science ®Google Scholar
• Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet monolayers by cytokines. Synergistic interactions of interferon-f-tumor necrosis factor, lymphotoxin and interleukin 1. Diabetes 1988; 37: 133–136
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Dinarello C A, Nerup J. Human tumor necrosis factor potentiates interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Egeberg Nerup J. J, Nielsen J H, Bendtzen K, Dinarello C A. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Path Microbiol Immunol Stand Sect C 1987; 95: 55–63
   PubMedGoogle Scholar
• Sumoski W, Baquerizo H, Rabinovitch A. Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 1989; 32: 792–796
   PubMed Web of Science ®Google Scholar
• Rabinovitch A, Baquerizo H, Sumoski W. Cytotoxic effects of cytokines on islet β-cells: evidence for involvement of eicosanoids. Endocrinology 1990; 126: 67–71
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Spinas G A, Prowse S J, Hansen B S, Jörgensen D, Bendtzen W. K, Nielsen J H, Nerup J. Islet cytotoxicity of interleukin 1: influence of culture conditions and islet donor characteristics. Diabetes 1987; 36: 641–647
   PubMed Web of Science ®Google Scholar
• Andersen H U, Mandrup-Poulsen T, Egeberg J, Helqvist S, Nerup J. Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat. Acta Endocrinol (Copenh) 1989; 120: 92–98
   PubMedGoogle Scholar
• Khatim M S, Bahr G M, Gumaa K A, Behbehani K. Effect of recombinant IL-1 isomers on fetal and adult islet cell function and replication. Diabetes Res 1988; 8: 25–29
   PubMedGoogle Scholar
• Palmer J P, Helqvist S, Spinas G A, Mølvig J, Mandrup-Poulsen T, Andersen H U, Nerup J. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhnns. Diabetes 1989; 38: 1211–1216
   PubMed Web of Science ®Google Scholar
• Johannesen J, Helqvist S, Nerup J. Not all insulin secreta-gogues sensitize pancreatic islets to recombinant human interleukin 1β. Acta Endocrinol (Copenh) 1990; 123: 445–452
   PubMedGoogle Scholar
• Dinarello C A. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311: 1413–1418
   PubMed Web of Science ®Google Scholar
• Yelich M R. In vivo endotoxin and IL-1 potentiate insulin secretion in pancreatic islets. Am J Physiol 1990; 258: R1070–R1077
   Google Scholar
• Cornell R P, Schwartz D B. Central administration of interleukin 1 elicits hyperinsulinemia in rats. Am J Physiol 1989; 256: R772–R777
   Google Scholar
• del Rey A, Besedovsky H. Antidiabetic effects of interleukin 1. Proc Natl Acad Sci USA 1989; 86: 5943–5947
   PubMed Web of Science ®Google Scholar
• Wogensen L D, Mandrup-Poulsen T, Markholst H, Mølvig J, Lernmark A, Hoist J J, Dinarello C A, Nerup J. Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas. Acta Endocrinol (Copenh) 1988; 117: 302–306
   PubMedGoogle Scholar
• Wogensen L, Helqvist S, Pociot F, Johannesen J, Reimers J, Mandrup-Poulsen T, Nerup J. Intra-peritoneal administration of interleukin-1β induces impaired insulin release from the perfused rat pancreas. Autoimmunity 1990; 7: 1–12
   PubMed Web of Science ®Google Scholar
• Wang Y, Goodman M, Lumerman J, Sussman K E, Dahl R, Lafferty K J, Draznin B. In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release. Diab Res Clin Pract 1989; 7: 205–211
   PubMed Web of Science ®Google Scholar
• Wilson C A, Jacobs C, Baker P, Baskin D G, Dower S K, Lernmark A, Tivola B, Vertrees S, Wilson D. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol 1990; 144: 3784–3788
   PubMed Web of Science ®Google Scholar
• Satoh J, Seino H, Shintani S, Tanaka S-I, Ohteki T, Masuda T, Nobunaga T, Toyota T. Inhibition of type 1 diabetes in BB rats with recombinant tumor necrosis factor-α. J Immunol 1990; 145: 1395–1399
   PubMed Web of Science ®Google Scholar
• Satoh J, Seino H, Abo T, Tanaka S-I, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Oteki T, Kumagai K, Toyota T. Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84: 1345–1348
   PubMed Web of Science ®Google Scholar
• Jacob C O, Aiso S, Michie S A, Mc Devitt H O, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc Natl Acad Sci USA 1990; 87: 968–972
   PubMed Web of Science ®Google Scholar
• Rhodes C J, Taylor K W. 2–5A-dependent endoribonuclease activity and effects of A2′ p5′ A2′ p5′A (2–5A core) in mouse pancreatic islets. FEBS Lett 1985; 180: 69–73
   PubMed Web of Science ®Google Scholar
• Jiang Z, Woda B A. Cytokine gene expression in the islets of the diabetic Bio Breeding/Worcester rat. J Immunol 1991; 146: 2990–2994
   PubMed Web of Science ®Google Scholar